WindRose Health Investors recapitalizes kidney health management company

In This List

Blog

Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns

Blog

Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders

Blog

Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up

Blog

Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps

27 May, 2019

Author Dawood Fakhir
Theme Healthcare & Pharmaceuticals Banking

Healthcare-focused private equity firm WindRose Health Investors LLC committed $85 million in financing to HealthMap Solutions LLC.

The kidney health management company will use the funds to expand its services and support its model of assuming risk for reducing the cost of care for patients with complex kidney health conditions.

VERSARi Private Capital Advisory helped arrange the financing for Healthmap, and Johnson Pope Bokor Ruppel & Burns LLP acted as legal adviser to the company.